AZN241206C00068000 Option on AstraZeneca PLC ADR

AZN Stock  USD 68.05  1.01  1.51%   

AstraZeneca PLC Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

AstraZeneca PLC Market Cap Over Time

   Market Cap   
       Timeline  

AstraZeneca Total Stockholder Equity

Total Stockholder Equity

41.1 Billion

At this time, AstraZeneca PLC's Total Stockholder Equity is very stable compared to the past year.

AstraZeneca PLC Corporate Directors

Marc DunoyerChief Financial Officer, Executive DirectorProfile
Sherilyn McCoyNon-Executive Independent DirectorProfile
Genevieve BergerNon-Executive Independent DirectorProfile
Nazneen RahmanNon-Executive Independent DirectorProfile
When determining whether AstraZeneca PLC ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AstraZeneca PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrazeneca Plc Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrazeneca Plc Adr Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.034
Dividend Share
2.97
Earnings Share
2.08
Revenue Per Share
2.7424
Quarterly Revenue Growth
0.18
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.